CN103509796B - 一种基于RNAi技术及rescue原理制备的siRNA和突变型克隆载体 - Google Patents
一种基于RNAi技术及rescue原理制备的siRNA和突变型克隆载体 Download PDFInfo
- Publication number
- CN103509796B CN103509796B CN201310399709.9A CN201310399709A CN103509796B CN 103509796 B CN103509796 B CN 103509796B CN 201310399709 A CN201310399709 A CN 201310399709A CN 103509796 B CN103509796 B CN 103509796B
- Authority
- CN
- China
- Prior art keywords
- spp1
- rnai
- gene
- seq
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000009368 gene silencing by RNA Effects 0.000 title claims abstract description 85
- 108091030071 RNAI Proteins 0.000 title claims abstract description 68
- 108020004459 Small interfering RNA Proteins 0.000 title claims abstract description 15
- 238000005516 engineering process Methods 0.000 title abstract description 9
- 101150063780 spp1 gene Proteins 0.000 claims abstract description 34
- 230000014509 gene expression Effects 0.000 claims abstract description 33
- 230000035772 mutation Effects 0.000 claims abstract description 20
- 230000008859 change Effects 0.000 claims abstract description 16
- 238000011160 research Methods 0.000 claims abstract description 8
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 claims description 19
- 108020004999 messenger RNA Proteins 0.000 claims description 19
- 102100030684 Sphingosine-1-phosphate phosphatase 1 Human genes 0.000 claims description 17
- 101710168942 Sphingosine-1-phosphate phosphatase 1 Proteins 0.000 claims description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 14
- 230000000692 anti-sense effect Effects 0.000 claims description 6
- 238000010367 cloning Methods 0.000 claims description 4
- 230000002452 interceptive effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 56
- 239000013598 vector Substances 0.000 abstract description 19
- 230000006870 function Effects 0.000 abstract description 16
- 238000000034 method Methods 0.000 abstract description 15
- 230000009467 reduction Effects 0.000 abstract description 7
- 230000003915 cell function Effects 0.000 abstract description 2
- 230000030279 gene silencing Effects 0.000 abstract description 2
- 230000008676 import Effects 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 description 52
- 238000001890 transfection Methods 0.000 description 19
- 239000002585 base Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 230000009182 swimming Effects 0.000 description 16
- 239000012634 fragment Substances 0.000 description 15
- 108091027967 Small hairpin RNA Proteins 0.000 description 14
- 241000700605 Viruses Species 0.000 description 14
- 239000004055 small Interfering RNA Substances 0.000 description 14
- 239000013642 negative control Substances 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 12
- 108090000790 Enzymes Proteins 0.000 description 12
- 230000009471 action Effects 0.000 description 11
- 108020004414 DNA Proteins 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 239000012531 culture fluid Substances 0.000 description 8
- 238000001962 electrophoresis Methods 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108091008146 restriction endonucleases Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000053602 DNA Human genes 0.000 description 7
- 239000001963 growth medium Substances 0.000 description 7
- 239000001110 calcium chloride Substances 0.000 description 6
- 229910001628 calcium chloride Inorganic materials 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102100031780 Endonuclease Human genes 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000001351 cycling effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 108010042407 Endonucleases Proteins 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 206010044565 Tremor Diseases 0.000 description 2
- 102000001400 Tryptase Human genes 0.000 description 2
- 108060005989 Tryptase Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 101150066555 lacZ gene Proteins 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000011022 operating instruction Methods 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003151 transfection method Methods 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101100352418 Caenorhabditis elegans plp-1 gene Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 101100236975 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GAL11 gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
纯化的DNA质粒(1ug/μl) | 2μl |
10×buffer | 5μl |
100×BSA | 0.5μl |
Hpa I(10U/μl) | 1μl |
Xho I(10U/μl) | 1μl |
H2O | 40.5μl |
Total | 50μl |
质粒(1ug/μl) | 2μl |
10×buffer | 5μl |
100×BSA | 0.5μl |
Age I(10U/μl) | 1μl |
H2O | 41.5μl |
Total | 50μl |
试剂 | 体积(μl) |
5×RT buffer | 4.0 |
10mM dNTPs | 2.0 |
RNasin | 0.5 |
M-MLV-RTase | 1.0 |
DEPC H2O | 3.5 |
Total | 11.0 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310399709.9A CN103509796B (zh) | 2013-09-05 | 2013-09-05 | 一种基于RNAi技术及rescue原理制备的siRNA和突变型克隆载体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310399709.9A CN103509796B (zh) | 2013-09-05 | 2013-09-05 | 一种基于RNAi技术及rescue原理制备的siRNA和突变型克隆载体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103509796A CN103509796A (zh) | 2014-01-15 |
CN103509796B true CN103509796B (zh) | 2017-01-04 |
Family
ID=49893230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310399709.9A Active CN103509796B (zh) | 2013-09-05 | 2013-09-05 | 一种基于RNAi技术及rescue原理制备的siRNA和突变型克隆载体 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103509796B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116650650A (zh) * | 2023-06-12 | 2023-08-29 | 郑州大学 | 一种抑制食管鳞癌中肿瘤相关巨噬细胞浸润的方法 |
-
2013
- 2013-09-05 CN CN201310399709.9A patent/CN103509796B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103509796A (zh) | 2014-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106834347A (zh) | 一种山羊cdk2基因敲除载体及其构建方法 | |
ES2665681T3 (es) | Preparaciones de ARN que comprenden ARN modificado purificado para reprogramar células | |
CN107760652A (zh) | CRISPR/CAS9介导药物转运体靶向性敲除的caco‑2细胞模型及其方法 | |
CN107502608A (zh) | 用于敲除人ALDH2基因的sgRNA、ALDH2基因缺失细胞株的构建方法及应用 | |
CN106957858A (zh) | 一种利用CRISPR/Cas9系统共同敲除绵羊MSTN、ASIP、BCO2基因的方法 | |
CN107338266A (zh) | 一种鉴定桑树MmPDS基因的VIGS沉默体系及其构建方法和应用 | |
CN105985978B (zh) | 一种新型rna环化表达载体的构建及其应用 | |
CN105624194A (zh) | 一种条件性诱导Cas9表达的猪滋养层细胞系及其建立方法和应用 | |
CN109182562A (zh) | 与蛋鸭卵泡发育相关的miRNA apla-mir-25-42及其检测引物、抑制物和应用 | |
CN108559731A (zh) | 一种可调控基因表达的人类胚胎干细胞系及其应用 | |
CN113308553B (zh) | 一种与羊骨骼肌发育相关的circRNA及其应用 | |
CN109402118B (zh) | 与蛋鸭卵泡发育相关的miRNA apla-mir-145-4及其检测引物、抑制物和应用 | |
Min et al. | Generation of antiviral transgenic chicken using spermatogonial stem cell transfected in vivo | |
CN113416768B (zh) | Prkra基因作为靶点在抑制小反刍兽疫病毒复制中的应用 | |
CN103509796B (zh) | 一种基于RNAi技术及rescue原理制备的siRNA和突变型克隆载体 | |
CN106987629A (zh) | 一种在单细胞水平上检测基因组上核小体排布的方法 | |
CN104232643B (zh) | RNAi干扰片段、干扰载体、制备方法及其应用 | |
CN104212837B (zh) | 表达人血清白蛋白的慢病毒载体及其构建方法 | |
CN105200059A (zh) | 靶向抑制小鼠UCP2基因表达的siRNA及其表达载体的构建 | |
CN103160514A (zh) | 人EBLN-1基因cDNA全长核苷酸序列及其克隆方法 | |
Shi et al. | Efficient and rapid fluorescent protein knock-in with universal donors in mouse embryonic stem cells | |
CN106632693A (zh) | 具有多个核定位序列的SpyCas9蛋白及其应用 | |
CN102703506A (zh) | α1,2-岩藻糖转移酶基因沉默的体细胞克隆猪及其生产方法与应用 | |
CN103695427A (zh) | 用于敲低vps11的小分子干扰rna、重组载体及其应用 | |
CN112011628A (zh) | 一种与湖羊肌肉细胞增殖相关的LncRNA标志物及其检测引物和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHANGHAI JIKAI GENE CHEMICAL TECHNOLOGY INC. Free format text: FORMER OWNER: SUZHOU GENECHEM TECHNOLOGY CO., LTD. Effective date: 20150721 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150721 Address after: 200233 room 619-21, Guiping Road, Shanghai, Xuhui District, 680 Applicant after: SHANGHAI GENECHEM Co.,Ltd. Address before: 215316, No. 757, North Road, Yushan, Kunshan, Jiangsu, Suzhou Applicant before: SUZHOU JIKAI GENE TECHNOLOGY Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: 200233, room 680, 619-21 Guiping Road, Shanghai, Xuhui District Patentee after: Shanghai Jikai gene Medical Technology Co.,Ltd. Address before: 200233, room 680, 619-21 Guiping Road, Shanghai, Xuhui District Patentee before: SHANGHAI GENECHEM Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231206 Address after: Room 805G, Building 5, No. 750 Linyuan Street, Zhujing Town, Jinshan District, Shanghai, 201500 Patentee after: Shanghai Jikai Biotechnology Co.,Ltd. Address before: Room 619-21, 680 Guiping Road, Xuhui District, Shanghai 200233 Patentee before: Shanghai Jikai gene Medical Technology Co.,Ltd. |